Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies

Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies

<p><strong>Background</strong><br> For blood-stage malaria vaccine development, the in vitro growth inhibition assay (GIA) has been widely used to evaluate functionality of vaccine-induced antibodies (Ab), and <em>Plasmodium falciparum</em> reticulocyte-binding pr...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Miura, K, Diouf, A, Fay, MP, Barrett, JR, Payne, RO, Olotu, AI, Minassian, AM, Silk, SE, Draper, SJ, Long, CA
Natura:	Journal article
Lingua:	English
Pubblicazione:	BioMed Central 2023

Documenti analoghi

Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
di: Kazutoyo Miura, et al.
Pubblicazione: (2023-05-01)

Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
di: Douglas, A, et al.
Pubblicazione: (2014)

Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria
di: Partey, F, et al.
Pubblicazione: (2018)

Targeting PfRh5 on Merozoites to Prevent Basigin Binding
di: Papadopoulos Konstantinos
Pubblicazione: (2012-10-01)

A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants
di: Bustamante, L, et al.
Pubblicazione: (2013)

Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
di: Frederica D Partey, et al.
Pubblicazione: (2018-01-01)

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
di: Weiss, GE, et al.
Pubblicazione: (2023)

Correction: Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
di: Frederica D Partey, et al.
Pubblicazione: (2018-01-01)

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
di: Williams, A, et al.
Pubblicazione: (2012)

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
di: Douglas, A, et al.
Pubblicazione: (2011)

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
di: Andrew R Williams, et al.
Pubblicazione: (2012-01-01)

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5
di: Harrison, TE, et al.
Pubblicazione: (2024)

The erythrocyte binding antigens and PfRh proteins are targets of Plasmodium falciparum invasioninhibitory antibodies.
di: Persson, K, et al.
Pubblicazione: (2008)

A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.
di: Douglas, A, et al.
Pubblicazione: (2015)

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.
di: Greta E Weiss, et al.
Pubblicazione: (2023-09-01)

The role of PfRh invasion ligands as targets of antibodies that protect against P-falciparum malaria.
di: Reiling, L, et al.
Pubblicazione: (2008)

Antibodies targeting the PfRH1 binding domain inhibit invasion of plasmodium falciparum merozoites
di: Iyer, Jayasree K., et al.
Pubblicazione: (2011)

Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytes
di: Lin Chen, et al.
Pubblicazione: (2014-10-01)

Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites.
di: Xiaohong Gao, et al.
Pubblicazione: (2008-07-01)

Functional characterization of plasmodium falciparum reticulocyte binding like protein homologue 1 (PfRH1)
di: Yap, Sally Shu Lin
Pubblicazione: (2015)

Insights into the design of an improved PfRH5 malaria immunogen using vaccine-induced monoclonal antibodies
di: Alanine, DGW
Pubblicazione: (2017)

The EBA and PfRh invasion ligand families of P-falciparum as targets of invasion-inhibitory and protective antibodies.
di: Beeson, J, et al.
Pubblicazione: (2008)

Plasmepsin X activates the PCRCR complex of Plasmodium falciparum by processing PfRh5 for erythrocyte invasion
di: Tony Triglia, et al.
Pubblicazione: (2023-04-01)

Establishment of an Antiplasmodial Vaccine Based on PfRH5-Encoding RNA Replicons Stabilized by Cationic Liposomes
di: Wesley L. Fotoran, et al.
Pubblicazione: (2023-04-01)

Assessing the functional impact of PfRh5 genetic diversity on ex vivo erythrocyte invasion inhibition
di: Adam J. Moore, et al.
Pubblicazione: (2021-01-01)

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
di: Thiam, LG, et al.
Pubblicazione: (2024)

Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5
di: Khadidiatou Mangou, et al.
Pubblicazione: (2022-11-01)

Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains.
di: Tony Triglia, et al.
Pubblicazione: (2011-06-01)

Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies
di: Willcox, AC, et al.
Pubblicazione: (2021)

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
di: Laty G. Thiam, et al.
Pubblicazione: (2024-10-01)

An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum.
di: Lin Chen, et al.
Pubblicazione: (2011-09-01)

Correction: PfRH5: A Novel Reticulocyte-Binding Family Homolog of that Binds to the Erythrocyte, and an Investigation of Its Receptor.
di: Marilis Rodriguez, et al.
Pubblicazione: (2008-01-01)

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5
di: Thomas E Harrison, et al.
Pubblicazione: (2024-09-01)

A DNA Vaccine Encoding <i>Plasmodium falciparum</i> PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization
di: Wesley Luzetti Fotoran, et al.
Pubblicazione: (2020-10-01)

Correction: PfRH5: A Novel Reticulocyte-Binding Family Homolog of Plasmodium falciparum that Binds to the Erythrocyte, and an Investigation of Its Receptor
Pubblicazione: (2008-01-01)

Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion.
di: Tajali Sahar, et al.
Pubblicazione: (2011-01-01)

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development
di: Mertens, JE, et al.
Pubblicazione: (2024)

Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening
di: Hojong Jun, et al.
Pubblicazione: (2024-11-01)

Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL
di: Labbé, GM, et al.
Pubblicazione: (2019)

Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
di: Nielsen, CM, et al.
Pubblicazione: (2023)